Successful treatment of serpiginous choroiditis with alkylating agents

Keyphrases

• Successful Treatment 100%
• Alkylating Agents 100%
• Serpiginous Choroiditis 100%
• Treatment Duration 33%
• Inflammation 16%
• Upper Tract Urothelial Carcinoma 16%
• Immunosuppression 16%
• Referral Center 16%
• Visual Loss 16%
• Long-term Prognosis 16%
• Clinical Disease Activity 16%
• Disease Remission 16%
• Cyclophosphamide 16%
• Tertiary Care 16%
• Prednisone 16%
• Nausea 16%
• Visual Acuity 16%
• Uveitis 16%
• Drug-free 16%
• Immunosuppressive Agents 16%
• Vision Threatening 16%
• Treatment-free Remission 16%
• Bone Marrow Suppression 16%
• Secondary Malignancy 16%
• Chlorambucil 16%
• Systemic Immunosuppression 16%
• Activity Duration 16%
• Active Vision 16%

Medicine and Dentistry

• Alkylating Antineoplastic Agent 100%
• Serpiginous Choroiditis 100%
• Immunosuppressive Treatment 33%
• Treatment Duration 33%
• Side Effect 33%
• Recurrent Disease 16%
• Cancer 16%
• Tertiary Care 16%
• Patient Referral 16%
• Carcinoma 16%
• Disease Activity 16%
• Bladder 16%
• Immunosuppressive Drug 16%
• Bone Marrow Suppression 16%
• Cyclophosphamide 16%
• Spontaneous Remission 16%
• Prednisone 16%
• Visual Acuity 16%
• Visual Impairment 16%
• Nausea 16%
• Uveitis 16%
• Chlorambucil 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Alkylating Agent 100%
• Choroiditis 100%
• Remission 33%
• Side Effect 33%
• Immunosuppressive Agent 16%
• Inflammation 16%
• Recurrent Disease 16%
• Disease Activity 16%
• Cyclophosphamide 16%
• Carcinoma 16%
• Bone Marrow Suppression 16%
• Prednisone 16%
• Nausea 16%
• Uveitis 16%
• Visual Impairment 16%
• Chlorambucil 16%